Erratum to: Safety and efficacy of an E2 glycoprotein subunit vaccine produced in mammalian cells to prevent experimental infection with bovine viral diarrhoea virus in cattle (Vet Res Commun, (2012), 36, (157-164), 10.1007/s11259-012-9526-x);Safety and efficacy of an E2 glycoprotein subunit vaccine produced in mammalian cells to prevent experimental infection with bovine viral diarrhoea virus in cattle

Veterinary Research Communications

Volumn 36, Issue 3, 2012, Pages 157-164

  Pecora, Andrea ^a   Pérez Aguirreburualde, María Sol ^a   Aguirreburualde, Alejandra ^b   Leunda, Maria Rosa ^a   Odeon, Anselmo ^a   Chiavenna, Sebastián ^a   Bochoeyer, Diego ^a   Spitteler, Marcelo ^b   Filippi, Jorge L ^b   Dus Santos, Maria J ^a   Levy, Susana M ^b   Wigdorovitz, Andrés ^a  

^a INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^b Biogenesis Bago   (Argentina)

Author keywords

BVDV; E2; Subunit vaccine; Vaccine potency

Indexed keywords

GLYCOPROTEIN E2; INACTIVATED VIRUS VACCINE; SUBUNIT VACCINE;

ANIMAL EXPERIMENT; ARTICLE; BOVINE VIRAL DIARRHEA; CATTLE DISEASE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; GUINEA PIG; HUMAN; IMMUNOGENICITY; LEUKOCYTE COUNT; MAMMAL CELL; NONHUMAN; PROVOCATION TEST; VIRUS ISOLATION;

ANIMALIA; BOS; BOVINAE; BOVINE VIRAL DIARRHEA VIRUS 1; CAVIA; FLAVIVIRIDAE; MAMMALIA; PESTIVIRUS;

EID: 84866664003     PISSN: 01657380     EISSN: 15737446     Source Type: Journal    
DOI: 10.1007/s11259-016-9660-y     Document Type: Erratum

References (27)

1. Bolin SR (1995) Control of bovine viral diarrhea infection by use of vaccination. Vet Clin N Am 11:615-625
2. Bolin SR, Ridpath JF (1995) Assessment of protection from systemic infection or disease afforded by low to intermediate titres of passively acquired neutralising antibody against bovine viral diarrhea virus in calves. Am J Vet Res 56:755-759
3. Bolin S, Moennig V, Kelso Gourley NE, Ridpath J (1988) Monoclonal antibodies with neutralising activity segregate isolates of bovine viral diarrhea virus into groups. Brief report. Archives of virology 99:117-123
4. Bolin SR, Ridpath JF, Black J, Macy M, Roblin R (1994) Survey of cell lines in the American Type Culture Collection for bovine viral diarrhea virus. Journal of virological methods 48:211-221
5. Chimeno Zoth S, Leunda MR, Odeón A, Taboga O (2007) Recombinant E2 glycoprotein of bovine viral diarrhea virus induces a solid humoral neutralizing immune response but fails to confer total protection in cattle. Brazilian Journal of Medical and Biological Research 40:813-818
6. Couvreur B, Letellier C, Olivier F, Dehan P, Elouahabi A, Vandenbranden M, Ruysschaert JM, Hamers C, Pastoret PP, Kerkhofs P (2007) Sequence-optimised E2 constructs from BVDV-1b and BVDV-2 for DNA immunisation in cattle. Vet Res 38:819-834
7. Donofrio G, Sartori C, Franceschi V, Capocefalo A, Cavirani S, Taddei S, Flammini CF (2008) Double immunisation strategy with a BoHV-4-vectorialized secreted chimeric peptide BVDV-E2/BoHV-1-gD. Vaccine 26:6031-6042
8. Elahi SM, Shen SH, Talbot BG, Massie B, Harpin S, Elazhary Y (1999) Recombinant adenoviruses expressing the E2 protein of bovine viral diarrhea virus induce humoral and cellular immune responses. FEMS Microbiol Lett 177:159-166
9. Ellis J, West K, Cortese V, Konoby C, Weigel D (2001) Effect of maternal antibodies on induction and persistence of vaccineinduced immune responses against bovine viral diarrhea virus type II in young calves. J Am Vet Med 219:351-356
10. Fernandez F, Costantini V, Barrandeguy M, Parreno V, Schiappacassi G, Maliandi F, Leunda M, Odeon A (2009) Evaluation of experimental vaccines for bovine viral diarrhea in bovines, ovines and guinea pigs. Rev Argent Microbiol 41:86-91
11. Ferrer F, Zoth SC, Calamante G, Taboga O (2007) Induction of virusneutralising antibodies by immunisation with Rachiplusia nu per os infected with a recombinant baculovirus expressing the E2 glycoprotein of bovine viral diarrhea virus. J Virol Meth 146:424-427
12. Harpin S, Hurley DJ, Mbikay M, Talbot B, Elazhary Y (1999) Vaccination of cattle with a DNA plasmid encoding the bovine viral diarrhoea virus major glycoprotein E2. J Gen Virol 80(Pt 12):3137-3144
13. Kohl W, Grone A, Moennig V, Herrler G (2007) Expression of the surface glycoprotein E2 of Bovine viral diarrhea virus by recombinant vesicular stomatitis virus. J Gen Virol 88:157-165
14. Kweon CH, Yoon YD, An SH, Lee YS (1997) Expression of envelope protein (E2) of bovine viral diarrhea virus in insect cells. J Vet Med Sci/J Vet Med Sci 59:415-419
15. Liang R, Babiuk LA, van Drunen Littel-van den Hurk S (2007) Compatibility of plasmids encoding bovine viral diarrhea virus type 1 and type 2 E2 in a single DNA vaccine formulation. Vaccine 25:5994-6006
16. Liang R, van den Hurk JV, Landi A, Lawman Z, Deregt D, Townsend H, Babiuk LA, van Drunen Littel-van den Hurk S (2008) DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge. J Gen Virol 89:453-466
17. Liess B, Orban S, Frey HR, Trautwein G, Wiefel W, Blindow H (1984) Studies on transplacental transmissibility of a bovine virus diarrhoea (BVD) vaccine virus in cattle. II. Inoculation of pregnant cows without detectable neutralising antibodies to BVD virus 90-229 days before parturition (51st to 190th day of gestation). Zentralblatt fur Veterinarmedizin. Reihe B. J Vet Med Sci 31:669-681
18. Marzocca MP, Seki C, Giambiagi SM, Robiolo B, Schauer R, Dus Santos MJ, Scodeller EA, La Torre JL, Wigdorovitz A and Grigera PR (2007) Truncated E2 of Bovine Viral Diarrhea Virus (BVDV) expresed in Drosophila melonogaster cells. A candidate antigen for a BVDV ELISA assay. J Virol Methods 144(1-2):49-56
19. Nobiron I, Thompson I, Brownlie J, Collins ME (2003) DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge. Vaccine 21:2082-2092
20. Pecora A, Perez Aguirreburualde MS, Rodriguez D, Seki C, Levy MS, Bochoeyer D, Dus Santos MJ, Wigdorovitz A (2009) Development and validation of an ELISA for quantitation of bovine viral diarrhea virus antigen in the critical stages of vaccine production. J Virol Meth 162:170-178
21. Pellerin C, van den Hurk J, Lecomte J, Tussen P (1994) Identification of a new group of bovine viral diarrhea virus strains associated with severe outbreaks and high mortalities. Virology 203:260-268
22. Rosas CT, Konig P, Beer M, Dubovi EJ, Tischer BK, Osterrieder N (2007) Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins. J Gen Virol 88:748-757
23. Roth JA, Kaeberle ML (1983) Suppression of neutrophil and lymphocyte function induced by a vaccinal strain of bovine viral diarrhea virus with and without the administration of ACTH. Am J Vet Res 44:2366-2372
24. Schmitt J, Becher P, Thiel HJ, Keil GM (1999) Expression of bovine viral diarrhoea virus glycoprotein E2 by bovine herpesvirus-1 from a synthetic ORF and incorporation of E2 into recombinant virions. J Gen Virol 80(Pt 11):2839-2848
25. Thiel et al (1996) Pestiviruses. In: Fields BN, Knipe DM, Howley PM (eds) Virology. Lippincott-Raven, Philadelphia, pp 1059-1073
26. Thomas C, Young NJ, Heaney J, Collins ME, Brownlie J (2009) Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus. Vaccine 27:2387-2393
27. Toth RL, Nettleton PF, McCrae MA (1999) Expression of the E2 envelope glycoprotein of bovine viral diarrhoea virus (BVDV) elicits virus-type specific neutralising antibodies. Vet Microbiol 65:87-101